Navigation Links
AvantGuard Low Binding Barrier Tips

ProductsAvantGuard Low Binding Barrier Tips
Company MIDSCI
Item AvantGuard Low Binding Barrier Tips
Features Inquire
Description AvantGard Low Binding 20l Barrier Tips. Low binding technology that significantly reduces the amount of DNA and proteins bound to the tip. Most other filter tips are advertised as low retention, which means the focus is on liquid not adhering to the pipet tip. However, AvantGard also focuses on low binding which reduces the binding of valuable molecules such as DNA, proteins, and enzymes which may still be retained even if all the liquid is expelled. High quality polyethylene barrier that prevents pipettor contamination. Most molecules cannot pass through the membrane so the pipettor shaft is protected from carry-over contamination. Tips are certified to be free of RNAse/DNAse and human DNA/PCR inhibitors as well as endotoxins. AvantGard tips are ideal for PCR; preventing carry-over contamination and binding less DNA and Taq to the sides of the tip. Each rack employs cells to cradle each tip, ensuring more stability for easier insertion of the pipettor. Racks also feature easy to use lift off lids.
Info MIDSCI
Customer Service: (800) 227-9997
Web site: http://www.midsci.com

Related medicine products :

1. AvantGuard Low Binding Barrier Tips, Eppendorf
2. AvantGuard Low Binding Barrier Tips, Long Reach
3. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
4. Acetylcholine Receptor (AChR) Binding Autoantibody RIA
5. Avant Premium Low Binding, Graduated, Pipet Tips
6. Avant E-Z Rack Premium Low Binding Microreach Pipet Tips
7. Avant E-Z Rack Premium Low Binding Pipet Tips
8. Avant Premium Low Binding, Graduated, Pipet Tips (P2 - P10)
9. Avant Premium Low Binding, Graduated, Long Reach Pipet Tips (P2 - P10)
10. Avant Premium Eppendorf Style Low Binding, Graduated, Pipet Tips
11. MBL Mannan Binding ELISA Kit
For the quantitative in vitro determination of Total Protein in serum and plasma...
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
Medicine Products:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: